This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of what to consider when planning or delivering health and social responses to drug-related problems in local communities, and reviews the...

In 2016, the World Health Assembly endorsed the first global health sector strategy on viral hepatitis. The aim of the strategy is to eliminate viral hepatitis as a major public health threat by 2030. In Europe, people who inject drugs (PWID) are at high risk of hepatitis C virus (HCV) and...

Injecting drugs is a key risk factor for contracting viral and other infections. Blood-borne infections acquired through the sharing of injecting equipment are among the most serious health harms of drug use. The drug-related infectious disease (DRID) indicator collects data on the extent of...

The aim of the literature review presented in this report was to provide evidence to inform the recommendations made by ECDC and the EMCDDA in the 2011 'Guidance on the prevention and control of infectious diseases among people who inject drugs'. The evidence presented here focuses on the...

Since the emergence of the HIV epidemic among people who inject drugs in the mid-1980s, many European countries have achieved substantial progress in implementing evidence-based measures to prevent and control infectious diseases among this group. In the 1990s, EU countries started to develop...

This publication is the result of a two-year project to publish European standards in drug prevention, co-funded by the European Commission (EC) (60 %) and the respective project partner organisations (40 %). The standards were developed by the Prevention Standards Partnership, a...

This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs. The guidance identifies seven key interventions which, in...

Since the emergence of the HIV epidemic among people who inject drugs in the mid-1980s, many European countries have achieved substantial progress in implementing evidence-based measures to prevent and control infectious diseases among this group. In the 1990s, EU countries started to develop...

This joint guidance by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) aims to support policy-makers and public health/social programme planners by providing an evidence base for developing national...

This report describes the methods and findings of a systematic review of mathematical modelling studies of the population-level impact of opioid agonist treatment (OAT) and needle and syringe programmes (NSPs) on hepatitis C virus (HCV) transmission among people who inject drugs (PWID). This...